Evidence map›Paper›PMID 30885919›Full record

ArticleHospital pediatrics2019

Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy.

Nathan M Krah, Tyler Bardsley, Richard Nelson, Lawanda Esquibel, Mark Crosby, Carrie L Byington, Andrew T Pavia, Adam L Hersh

Abstract readComparative Study
In one paragraph

Article in Hospital pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Nathan M KrahInfectious Disease, Department of Pediatrics, School of Medicine and.
Tyler BardsleyDivisions of Epidemiology and.
Richard NelsonDivisions of Epidemiology and.
Lawanda EsquibelInfectious Disease, Department of Pediatrics, School of Medicine and.
Mark CrosbyIntermountain Homecare Pharmacy, Intermountain Healthcare, Salt Lake City, Utah; and.
Carrie L ByingtonCollege of Medicine, Texas A&M University, Bryan, Texas.
Andrew T PaviaInfectious Disease, Department of Pediatrics, School of Medicine and.
Adam L HershInfectious Disease, Department of Pediatrics, School of Medicine and adam.hersh@hsc.utah.edu.
Intermountain Healthcare · USTexas A&M University · USUniversity of Utah · USVA Salt Lake City Healthcare System · US

Funding

Development of clinical decision tools for management of diarrhea of children in high and low resource settingsR01AI135114 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI LEUNG, DANIEL TED · 2018 to 2025
$4.0M
Performance Validation of a Multiplexed IVD System for Gastrointestinal PathogensR01AI104593 · NIAID · BIOFIRE DIAGNOSTICS, LLC · PI BOURZAC, KEVIN M · 2013 to 2015
$3.6M
Risk Stratification and Decision Support to Improve Care and Outcomes in Children with PneumoniaR01AI125642 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, DEREK J. · 2017 to 2021
$3.3M
Using CER to Improve Antibiotic Prescribing and Outcomes in ChildrenK08HS023320 · AHRQ · UNIVERSITY OF UTAH · PI HERSH, ADAM L. · 2014 to 2018
$801k
AHRQ HHS K08 HS023320NIAID NIH HHS R01 AI104593NIAID NIH HHS R01 AI125642NIAID NIH HHS R01 AI135114
6 · The paper itself

Abstract

backgroundThere is increasing evidence that outpatient parenteral antimicrobial therapy (OPAT) is overused for children and that outcomes with oral therapy are equivalent. Our objective was to compare economic burden between OPAT and oral therapy, accounting for direct and indirect costs and caregiver quality of life (QoL).

methodsWe conducted a prospective cohort study of caregivers for children after hospitalization who were treated with prolonged antimicrobial therapy. We collected data about missed work and school and time spent administering therapy. Caregivers completed the Pediatric Quality of Life Inventory to assess QoL. Clinical information included length of stay, treatment indication, and type of therapy (OPAT versus oral therapy). Direct medical costs were obtained by using a microcosting system and accounted for medication, supplies, and home-nursing visits. The primary cost outcome was the mean daily cost of therapy. Multivariable models were developed to adjust for potential confounders.

resultsTwo hundred and twelve caregivers completed surveys: 123 (58%) for oral therapy and 89 (42%) for OPAT. Caregivers administering OPAT reported more missed work, missed school for their children, time with daily medication administration (90 vs 6 minutes;

conclusionsThe overall burden of OPAT is substantially higher than that of oral therapy, including higher direct and indirect costs and greater impact on caregiver QoL. These findings strongly support efforts to use oral therapy in place of OPAT when clinically appropriate.

Indexed as

Cost of IllnessAdministration, IntravenousAdministration, OralAmbulatory CareAnti-Bacterial AgentsCaregiversChildFemaleHome Infusion TherapyHumansMaleProspective StudiesAnti-Bacterial Agents

Identifiers

PMID30885919
PMCPMC6434972
OpenAlexW2930249196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.